Looking to capitalize on Philadelphia’s emergence as a national hub for cell and gene therapy, Gattuso Development and project partner Vigilant Holdings of New York have secured a $290 million construction loan to build an 11-story life science research and lab facility at 3201 Cuthbert Street in the center of Philadelphia’s University City submarket.